Budapest, Hungary, December 29, 2012 – Today Omixon – a genomics software company – announces the release of Omixon Target 1.2 which includes a free Genome Browser. With the Genome Browser users can visualize next generation sequencing and mutation data. The Browser is especially designed for targeted genomic regions.
”Users can view, navigate and analyze genomic variants, display the level of details needed and zoom in to examine the underlying short read data, to verify the variant call,” says Omixon CEO Attila Berces.
“NGS is rapidly being adopted by clinical and research laboratories worldwide. Easy to use analytical methods and software like Omixon are critical for the success of this ground breaking new technology.” said Lajos Pusztai, M.D, PhD. Chief of Breast Medical Oncology Co-Director of the Yale Cancer Center Genetics and Genomics Program Yale School of Medicine.
New features in the Omixon Target HLA typing module include the ability to manually assign alleles, in addition to the application’s existing ablility to do so automatically. New algorithms for enhanced performance on the Ion Torrent and Roche 454 platforms are included with the release.
According to Omixon CTO, Tim Hague, ”this release is a continuation of our commitment to enhance the ability to analyze clinically and diagnostically relevant NGS data.”
Omixon’s mission is to help clinical, diagnostic and research labs to adopt NGS (Next Generation Sequencing) for the benefit of patients, by providing precise and validated data analysis software. Using our Target application suite we help scientists and clinicians to investigate challenging genomic regions, such as breast cancer susceptibility genes (BRCA1 and BRCA2), cystic fibrosis gene (CFTR), as well as custom panels.